Moreover, Martin-Orozco et al., showed that tumor growth is increased in IL-17A-deficient mice injected intravenously with B16-F10 melanoma cells and that Th17 cells mediate the activation of tumor-specific cytotoxic T cells [128]. This evidence concerns the gene IL17A and neoplasm.